Jonathan Robert Hunt - 13 Nov 2025 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Reporting relationship: Chief Accounting Officer
Issuer ticker: CATX
Reported as of: 13 Nov 2025
Net transaction value: +$22,295
SEC form: 4
Accepted by SEC: 17 Nov 2025, 08:01:56 UTC
Prior SEC filing: 05 Mar 2025
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact

Key filing fact

Jonathan Robert Hunt filed Form 4 for Perspective Therapeutics, Inc. (CATX) on 17 Nov 2025.

Key facts

This page summarizes Jonathan Robert Hunt's Form 4 filing for Perspective Therapeutics, Inc. (CATX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Nov 2025, 08:01.

Change

Previous filing in this sequence was filed on 05 Mar 2025.
Current net transaction value: +$22,295.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001375410 Primary reporting owner

Hunt Jonathan Robert

Relationship: Chief Accounting Officer
Address: C/O PERSPECTIVE THERAPEUTICS, INC., 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE
Signature: /s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact
Signature date: 17 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CATX transaction

Common Stock

Purchase

Transaction value: $22,295
Shares: +11,000
Change %: +23%
Price: $2.03
Shares after: 59,800
Date: 13 Nov 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.0235 to $2.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.